Synergy Innovation Co., Ltd.
Financials
Valuation Metrics
Synergy Innovation Co., Ltd.'s Market Cap is ₩1436B. At end of 2025 it was ₩2066B. Ranked #1008 of 2,436 in KR market (top 41%), #500 of 1,649 on KOSDAQ (top 30%), #34 of 96 in Health Care Equipment & Services (top 35%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 143.61B KRW | KR#1,008/2,436 Sec#34/96 |
| Revenue | 112.84B KRW | KR#1,332/2,436 Sec#27/96 |
| Net Income | 14.28B KRW | KR#770/2,436 Sec#19/96 |
| Total Assets | 335.01B KRW | KR#952/2,436 Sec#19/96 |
| Net Assets | 274.87B KRW | KR#735/2,436 Sec#15/96 |
| Employees | 69 | KR#1,867/2,436 Sec#74/96 |
| Value | ||
| P/E | 10.06x | KR#719/2,436 Sec#19/96 |
| P/B | 0.52x | KR#845/2,436 Sec#13/96 |
| PEG | 0.08x | KR#363/2,436 Sec#11/96 |
| P/S | 1.27x | KR#1,558/2,436 Sec#39/96 |
| EV/EBITDA | 6.69x | KR#359/2,436 Sec#8/96 |
| FCF Yield | 6.55% | KR#778/2,436 Sec#19/96 |
| Profitability | ||
| ROE | 5.19% | KR#972/2,436 Sec#35/96 |
| ROA | 4.26% | KR#748/2,436 Sec#32/96 |
| Op. Margin | 16.13% | KR#245/2,436 Sec#21/96 |
| Revenue Growth | -0.77% | KR#1,484/2,436 Sec#66/96 |
| Earnings Growth | 121.19% | KR#370/2,436 Sec#15/96 |
| Financial Health | ||
| Debt Ratio | 21.88% | KR#58/2,436 Sec#3/96 |
| Total Debt | 24.03B KRW | KR#1,289/2,436 Sec#35/96 |
| FCF | 9.41B KRW | KR#721/2,436 Sec#17/96 |
| Cash | 45.85B KRW | KR#791/2,436 Sec#13/96 |
| Current Ratio | 3.91x | KR#432/2,436 Sec#28/96 |
| Net Debt/EBITDA | -1.20x | KR#425/2,436 Sec#13/96 |
| Dividend | ||
| Div. Yield | 2.28% | KR#836/2,436 Sec#19/96 |
| Div. Growth | 25.73% | KR#374/2,436 Sec#14/96 |
| Performance | ||
| 1Y Return | -42.40% | KR#1,898/2,436 Sec#69/96 |
| 1M Return | -4.68% | KR#1,368/2,436 Sec#61/96 |
| From 52W High | -47.42% | KR#1,076/2,436 Sec#41/96 |
| 1Y MDD | -52.85% | KR#1,052/2,436 Sec#35/96 |
| Trading | ||
| Volume | 471,211 shares | KR#293/2,436 Sec#8/96 |
| Foreign Own. | 14.46% | KR#325/2,436 Sec#10/96 |
| Per Share | ||
| EPS | 69 KRW | KR#1,415/2,436 Sec#44/96 |
| BPS | 2,429 KRW | KR#1,929/2,436 Sec#60/96 |
Company Info
Synergy Innovation, established in 1998 and listed on KOSDAQ in 2004, is a specialized microorganism culture media manufacturing company with five subsidiaries. It operates biotechnology, medical, and health functional food businesses, including investing in new drug development for brain and central nervous system diseases through Neurobiogen. The company produces in-vitro diagnostic and environmental monitoring products in ISO13485 and KGMP-certified environments, focusing on manufacturing facility expansion and production automation from 2024, from its headquarters in Seongnam-si, Gyeonggi-do.